Table 5.
Receptor | Radiolabeled Ligand |
Ligand Classification |
Species | Ki (nM) | Reference |
---|---|---|---|---|---|
5-HT1A | 3H-8-OH-DPAT | Agonist | Human | >10,000 | 77 |
5-HT1A | 3H-8-OH-DPAT | Agonist | Human | 12,200 | 62 |
5-HT 1B | 3H-GR-125743 | Antagonist | Human | >10,000 | 77 |
5-HT 1D | 3H-GR-125743 | Antagonist | Human | >10,000 | 77 |
5-HT 1E | 3H-5-HT | Agonist | Human | >10,000 | 77 |
5-HT2A | 3H-Ketanserin | Antagonist | Rat | >10,000 | 77 |
5-HT2A | 3H-Ketanserin | Antagonist | Human | 7,800 | 62 |
5-HT2B | 3H-LSD | Agonist | Human | 500 | 77 |
5-HT2C | 3H-Mesulergine | Antagonist | Rat | >10,000 | 77 |
5-HT2C | 3H-Mesulergine | Antagonist | Human | >13,000 | 62 |
5-HT3 | 3H-Zacopride | Antagonist | Human | >10,000 | 77 |
5-HT5 | 3H-LSD | Agonist | Human | >10,000 | 77 |
5-HT6 | 3H-LSD | Agonist | Human | >10,000 | 77 |
5-HT7 | 3H-LSD | Agonist | Human | >10,000 | 77 |
Alpha1A | 125I-HEAT | Antagonist | Human | >10,000 | 77 |
Alpha1A | 3H-Prazosin | Inverse Agonist | Human | >6,000 | 62 |
Alpha1B | 125I-HEAT | Antagonist | Human | >10,000 | 77 |
Alpha2A | 3H-Clonidine | Agonist | Human | 2,532 | 77 |
Alpha2A | 3H- Rauwolscine | Antagonist | Human | 15,000 | 62 |
Alpha2B | 3H-Clonidine | Agonist | Human | 1,785 | 77 |
Alpha2C | 3H-Clonidine | Agonist | Human | 1,123 | 77 |
Beta1 | 125I-Pindolol | Partial Agonist | Rat | >10,000 | 77 |
Beta2 | 125I-Pindolol | Partial Agonist | Rat | >10,000 | 77 |
CB1 | 3H-CP-55940 | Agonist | Rat (brain) | >10,000 | 77 |
M1 | 3H-QNB | Antagonist | Human | >10,000 | 77 |
M2 | 3H-QNB | Antagonist | Human | >10,000 | 77 |
M3 | 3H-QNB | Antagonist | Human | 1,851 | 77 |
M4 | 3H-QNB | Antagonist | Human | 8,245 | 77 |
M5 | 3H-QNB | Antagonist | Human | 6,339 | 77 |
Nicotinic Alpha1Beta2 |
3H-Epibatidine | Agonist | Human | >10,000 | 77 |
Nicotinic Alpha2Beta2 |
3H-Epibatidine | Agonist | Human | >10,000 | 77 |
Nicotinic Alpha2Beta4 |
3H-Epibatidine | Agonist | Human | >10,000 | 77 |
Nicotinic Alpha3Beta2 |
3H-Epibatidine | Agonist | Human | >10,000 | 77 |
Nicotinic Alpha3Beta4 |
3H-Epibatidine | Agonist | Human | >10,000 | 77 |
Nicotinic Alpha7 | 3H-Epibatidine | Agonist | Human | >10,000 | 77 |
D1 | 3H-SCH23390 | Antagonist | Human | >10,000 | 77 |
D1 | 3H-SCH23390 | Antagonist | Human | >13,600 | 62 |
D2 | 3H-NMSP | Antagonist | Human | >10,000 | 77 |
D2 | 3H-Spiperone | Antagonist | Human | 25,200 | 62 |
D3 | 3H-NMSP | Antagonist | Human | >10,000 | 77 |
D3 | 3H-Spiperone | Antagonist | Human | >17,700 | 62 |
D4 | 3H-NMSP | Antagonist | Rat | >10,000 | 77 |
D5 | 3H-SCH23390 | Antagonist | Human | >10,000 | 77 |
GABA A | 3H-Muscimol | Agonist | Rat (forebrain) | >10,000 | 77 |
GABA B | 3H-Baclofen | Agonist | Rat (forebrain) | >10,000 | 77 |
NMDA | 3H-MK-801 | Antagonist | Rat (forebrain) | >10,000 | 77 |
H1 | 3H-Pyrilamine | Antagonist | Human | 2,138 | 77 |
H1 | 3H-Pyrilamine | Antagonist | Human | >14,400 | 62 |
H2 | 3H-Pyrilamine | Antagonist | Human | >10,000 | 77 |
Prostaglandin EP3 | 3H-PGE2 | Agonist | Human | >10,000 | 77 |
Prostaglandin EP4 | 3H-PGE2 | Agonist | Human | >10,000 | 77 |
NET | 3H-Nisoxetine | Inhibitor | Human | >10,000 | 77 |
NET | 3H-Nisoxetine | Inhibitor | Human | 30,500 | 62 |
DAT | 3H-GBR 12935 | Inhibitor | Human | >10,000 | 77 |
DAT | 3H-WIN35,428 | Inhibitor | Human | 6,500 | 62 |
SERT | 3H-Citalopram | Inhibitor | Human | >10,000 | 77 |
SERT | 3H-Citalopram | Inhibitor | Human | 13,300 | 62 |
TAAR1 | 3H-RO5166017 | Agonist | Rat | 370 | 62 |
TAAR1 | 3H-RO5166017 | Agonist | Mouse | 2,400 | 62 |